Thomas Jahn

Head of Cardiopulmonary Disease
Thomas Jahn

Thomas leads the Cardiopulmonary Biology team for Dewpoint Therapeutics. Most recently, he was a Group Leader in the Neuroscience Discovery organization at AbbVie in Germany.

During his career in academia and pharmaceutical research, Thomas has founded a research laboratory at the German Cancer Research Center in Heidelberg focusing on generic concepts of protein misfolding disorders and has held a range of leadership roles for pre-clinical drug discovery projects. He has key expertise in establishing innovative disease models and translational strategies, and enjoys developing new therapeutic modalities for challenging drug discovery targets.

Thomas is a biochemist by training, holds a Ph.D. in Structural Biology from the University of Leeds and has performed his postdoctoral work at the University of Cambridge.

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science